JPRN-jRCTc030190247SuspendedPhase 1
Treatment of bone defects in the craniofacial region using an artificial bone fabricated with highly functional scaffold materials and a 3-dimensional printer, and autologous bone marrow fluid. - Treatment of bone defects using a 3D-printed artificial bone and bone marrow fluid.
Hoshi Kazuto0 sites3 target enrollmentStarted: March 16, 2020Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 1
- Status
- Suspended
- Sponsor
- Enrollment
- 3
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- >= 20age old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- •A patient who meets all the criteria described below is included in the research.
- •1. A patient with defect or dysplasia of craniofacial bone (non-weight bearing site), who needs transplantation of bone less than about 10 mL (judged by X-ray or CT-scanning taken at a normal medical examination within 1 year before the time of obtaining informed consent).
- •2. A patient who can follow the schedule specified in the protocol.
- •3. A patient of 20 years or more at the time of obtaining informed consent.
- •4. A patient who can understand the contents of the research and give a written informed consent.
Exclusion Criteria
- •A patient who meets any of the criteria described below is excluded from the research.
- •1. A patient who is classified as III or more in ASA physical status classification.
- •2. A patient who has malignancy, or possibility of malignancy.
- •3. A patient who has ill-controlled diabetes mellitus.
- •4. A patient who has possibility of sepsis.
- •5. A patient who has infection with possibility of recurrence around the site of transplantation or collection of bone marrow fluid.
- •6. A patient who underwent surgery within 1 year at the site of the transplantation before transplantation of AMED-Bone+BM, or who is going to receive surgery at the site of the transplantation.
- •7. A patient who has diseases in bone marrow such as fibrosis, dysplasia or hematopoietic disorder.
- •8. A female patient who is pregnant, has possibility of pregnancy, is breast-feeding, or disagrees with contraception until 6 months after transplantation of AMED-Bone+BM.
- •9. A patient who, or whose relatives within the second degree, have present or past history of autoimmune diseases such as rheumatoid arthritis, psoriatic arthropathy, systemic or discoid lupus erythematosus, dermatomyositis, polymyositis, chronic thyroiditis, Graves' disease, polyarteritis, scleroderma, ulcerous colitis, Crohn's disease, Sjoegren syndrome, Reiter's syndrome, mixed connective-tissue disease, or relapsing polychondritis.
- •10. A patient with the history of anaphylaxis.
- •11. A patient with the history of hypersensitivity or allergy to collagen products, or possibility of them.
- •12. A patient who is receiving immunosuppressive agents.
- •13. A patient who is taking anti-coagulant agents and not able to withdraw them during surgery and 1 week after surgery not to affect coagulability.
- •14. A patient who has been enrolled in other clinical trials or clinical researches within 90 days before the time of obtaining informed consent.
- •15. A patient with mental disorders who cannot fill in the questionnaire adequately.
- •16. A patient whom the principal investigator or sub-investigators consider inadequate to enroll in this research by other reasons.
Investigators
Similar Trials
Not yet recruiting
Not Applicable
Restoration of bone defects at craniotomy using bone graft substitutes made of hydroxyapatite and collagen composite.Bone defect caused by craniotomyJPRN-UMIN000035228Shimane University Faculty of Medicine Department of Neurosurgery31
Recruiting
Not Applicable
ew Therapies for bone and cartilage defects using bone marrow1002321310046304NL-OMON43408Orthopaedie200
Not yet recruiting
Not Applicable
Treatment of skeletal 2 malocclusions with temporary anchorage devices and elastics.ACTRN12610000205033Australian Society of Orthodontists20
Completed
Phase 1
Management of bone loss by surgery using synthetic ceramics loaded with stem cellsCTRI/2014/09/005027Department of Biotechnology10
Recruiting
Phase 2
correction of old nasal bone deviatioose deviation.Deviated nasal septumJ34.2IRCT20151123025202N5Hamedan University of Medical Sciences30